Capstone serves as the parent organization for Celerity Pharmaceuticals, Gage Development, and Balmoral Medical, all of which contribute to our client-focused development efforts. Additionally, Capstone is the holding company for Long Grove Pharmaceuticals, specializing in the production of complex generic and proprietary products through distinct regulatory pathways (the ANDA and 505(b)(2) pathways). Formed in 2013, Capstone is a subsidiary of Water Street Healthcare Partners, a strategic investor with a dedicated focus on the healthcare sector.